Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Ahead of print

Issues

Sample dilution for soluble interleukin-2 receptor α measurement: comparison of two different matrices

Shunzong YuanORCID iD: https://orcid.org/0000-0002-8981-0397 / Bing Qiao
  • Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th Hospital of the PLA), Beijing, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Naxin Zheng
  • Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th Hospital of the PLA), Beijing, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Wenwen Zheng
  • Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th Hospital of the PLA), Beijing, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Huarong Jing
  • Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th Hospital of the PLA), Beijing, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Guanhui Wen
  • Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th Hospital of the PLA), Beijing, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Shiping Song
  • Corresponding author
  • Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th Hospital of the PLA), Beijing, P.R. China
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2019-08-31 | DOI: https://doi.org/10.1515/cclm-2019-0430

References

  • 1.

    Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, YarchoanR, et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985;135:3172–7.PubMedGoogle Scholar

  • 2.

    Komp DM, McNamara J, Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood 1989;73:2128–32.PubMedGoogle Scholar

  • 3.

    Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 2007;56:965–71.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 4.

    Grimm J, Zeller W, Zander AR. Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantations as a marker for GVHD. Bone Marrow Transplant 1998;21:29–32.PubMedCrossrefGoogle Scholar

  • 5.

    Bien E, Balcerska A. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review. Biomarkers 2008;13:1–26.CrossrefPubMedGoogle Scholar

  • 6.

    Boyano MD, Garcia-Vazquez MD, Lopez-Michelena T, GardeazabalJ, Bilbao J, Canavate ML, et al. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma. Br J Cancer 2000;83:847–52.CrossrefPubMedGoogle Scholar

  • 7.

    Vorselaars AD, van Moorsel CH, Zanen P, Ruven HJ, Claessen AM, van Velzen-Blad H, et al. ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy. Respir Med 2015;109:279–85.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 8.

    Niitsu N, Iijima K, Chizuka A. A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin’s lymphoma. Eur J Haematol 2001;66:24–30.PubMedCrossrefGoogle Scholar

  • 9.

    Ambrosetti A, Nadali G, Vinante F, Carlini S, Veneri D, TodeschiniG, et al. Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcome. Cancer 1993;72:201–6.PubMedCrossrefGoogle Scholar

  • 10.

    Berthier F, Lambert C, Genin C, Bienvenu J. Evaluation of an automated immunoassay method for cytokine measurement using the Immulite Immunoassay system. Clin Chem Lab Med 1999;37:593–9.PubMedGoogle Scholar

  • 11.

    Rothkrantz-Kos S, Drent M, Schmitz MP, Menheere PP, van Dieijen-Visser MP. Reference values of soluble interleukin-2 receptor on the IMMULITE. Clin Chem Lab Med 2004;42:976–7.PubMedGoogle Scholar

  • 12.

    Hayden A, Lin M, Park S, Pudek M, Schneider M, Jordan MB, et al. Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH. Blood Adv 2017;1:2529–34.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 13.

    Lin M, Park S, Hayden A, Giustini D, Trinkaus M, Pudek M, et al. Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review. Ann Hematol 2017;96:1241–51.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 14.

    Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, ImashukuS, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124–31.PubMedWeb of ScienceCrossrefGoogle Scholar

About the article

Corresponding author: Prof. Shiping Song, Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th Hospital of the PLA), Beijing 100071, P.R. China

aShunzong Yuan and Bing Qiao contributed equally to this work.


Received: 2019-04-24

Accepted: 2019-08-04

Published Online: 2019-08-31


Funding Source: National Natural Science Foundation of China

Award identifier / Grant number: 81370631

Award identifier / Grant number: 81770207

SY is supported by grants from the National Natural Science Foundation of China (Funder Id: http://dx.doi.org/10.13039/501100001809, 81370631 and 81770207), Beijing Municipal Science and Technology Commission (Grant No.: Z161100000516183). SS is supported by the grant from the former 307th hospital of the PLA internal project (AWS14C014).


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organizations played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication. None of the authors have any conflict of interest to report.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), 20190430, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2019-0430.

Export Citation

© 2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in